BLTE
Price
$59.04
Change
-$0.86 (-1.44%)
Updated
Jun 27 closing price
Capitalization
1.92B
38 days until earnings call
URGN
Price
$13.49
Change
+$0.38 (+2.90%)
Updated
Jun 27 closing price
Capitalization
621.99M
51 days until earnings call
Interact to see
Advertisement

BLTE vs URGN

Header iconBLTE vs URGN Comparison
Open Charts BLTE vs URGNBanner chart's image
Belite Bio
Price$59.04
Change-$0.86 (-1.44%)
Volume$31.5K
Capitalization1.92B
UroGen Pharma
Price$13.49
Change+$0.38 (+2.90%)
Volume$2.27M
Capitalization621.99M
BLTE vs URGN Comparison Chart in %
Loading...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
URGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLTE vs. URGN commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLTE is a Buy and URGN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (BLTE: $59.04 vs. URGN: $13.49)
Brand notoriety: BLTE and URGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BLTE: 104% vs. URGN: 63%
Market capitalization -- BLTE: $1.92B vs. URGN: $621.99M
BLTE [@Biotechnology] is valued at $1.92B. URGN’s [@Biotechnology] market capitalization is $621.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLTE’s FA Score shows that 0 FA rating(s) are green whileURGN’s FA Score has 0 green FA rating(s).

  • BLTE’s FA Score: 0 green, 5 red.
  • URGN’s FA Score: 0 green, 5 red.
According to our system of comparison, URGN is a better buy in the long-term than BLTE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLTE’s TA Score shows that 3 TA indicator(s) are bullish while URGN’s TA Score has 6 bullish TA indicator(s).

  • BLTE’s TA Score: 3 bullish, 6 bearish.
  • URGN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, URGN is a better buy in the short-term than BLTE.

Price Growth

BLTE (@Biotechnology) experienced а -2.38% price change this week, while URGN (@Biotechnology) price change was -7.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

BLTE is expected to report earnings on Aug 06, 2025.

URGN is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLTE($1.92B) has a higher market cap than URGN($622M). URGN YTD gains are higher at: 26.667 vs. BLTE (-6.434). BLTE has higher annual earnings (EBITDA): -43.31M vs. URGN (-119.79M). URGN has more cash in the bank: 196M vs. BLTE (145M). BLTE has less debt than URGN: BLTE (537K) vs URGN (125M). URGN has higher revenues than BLTE: URGN (91.9M) vs BLTE (0).
BLTEURGNBLTE / URGN
Capitalization1.92B622M309%
EBITDA-43.31M-119.79M36%
Gain YTD-6.43426.667-24%
P/E RatioN/AN/A-
Revenue091.9M-
Total Cash145M196M74%
Total Debt537K125M0%
FUNDAMENTALS RATINGS
URGN: Fundamental Ratings
URGN
OUTLOOK RATING
1..100
93
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BLTEURGN
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
Bearish Trend 3 days ago
72%
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
77%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 10 days ago
76%
Bullish Trend 14 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
65%
Bearish Trend 3 days ago
79%
Aroon
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
URGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
UBPIX15.310.09
+0.59%
ProFunds UltraLatin America Inv
RGGYX25.650.15
+0.59%
Victory RS Global Y
ITHAX43.270.25
+0.58%
Hartford Capital Appreciation A
REQSX22.730.07
+0.31%
Russell Inv Equity Income C
NVSCX31.190.06
+0.19%
Allspring Small Company Growth Admin

BLTE and

Correlation & Price change

A.I.dvisor tells us that BLTE and ACOG have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BLTE and ACOG's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLTE
1D Price
Change %
BLTE100%
-1.44%
ACOG - BLTE
27%
Poorly correlated
-1.14%
FGHQF - BLTE
25%
Poorly correlated
N/A
URGN - BLTE
23%
Poorly correlated
+2.90%
ELVN - BLTE
23%
Poorly correlated
-3.95%
HRMY - BLTE
22%
Poorly correlated
+0.38%
More

URGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, URGN has been loosely correlated with AIM. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if URGN jumps, then AIM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To URGN
1D Price
Change %
URGN100%
+2.90%
AIM - URGN
39%
Loosely correlated
-7.04%
ETNB - URGN
38%
Loosely correlated
-0.90%
ATXS - URGN
36%
Loosely correlated
N/A
SCPH - URGN
36%
Loosely correlated
-2.76%
PHAT - URGN
35%
Loosely correlated
+1.99%
More